Search

Issue
Title
Authors
Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry
Chazova I.E., Arkhipova O.A., Martynyuk T.V.
Therapies of chronic thromboembolic pulmonary hypertension: A review
Vasiltseva O.Y., Edemskiy A.G., Zeinalov D.F., Kliver E.N., Ussov W.Y., Grankin D.S., Sirota D.A., Chernyavskiy A.M.
Influence of demographic characteristics on the clinical course and results of therapy in patients with precapillary pulmonary hypertension
Taran I.N., Valieva Z.S., Belevskaya A.A., Saidova M.A., Martynyuk T.V., Chazova I.E.
Problematic aspects of pulmonary hypertension due to left heart disease: focus on combined postcapillary and precapillary pulmonary hypertension
Aleevskaya A.M., Vyborov O.N., Gramovich V.V., Martynyuk T.V.
Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world
Zakiev V.D., Gvozdeva A.D., Martynyuk T.V.
Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry
Chazova I.E., Valieva Z.S., Nakonechnikov S.N., Taran I.N., Martynyuk T.V.
Rehabilitation in patients with chronic thromboembolic pulmonary hypertension
Sagaydak O.V., Danilov N.M., Chazova I.E.
Evidence base for specific pulmonary vasodilators in adults with congenital heart disease
Shmalts A.A., Gorbachevsky S.V.
SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS
Neklyudova G.V., Avdeev S.N., Tsareva N.A., Chernyaev A.L., Samsonova M.V., Naumenko Z.K., Mikhale L.M.
Combination therapy is a new standard for treatment of pulmonary arterial hypertension
Avdeev S.N., Tsareva N.A., Gaisin I.R.
Applying of magnetic resonance tomography for assessment of cardiac remodeling and risk stratification in patients with pulmonary arterial hypertension
Shariya A.M., Martynyuk T.V., Shariya M.A., Ustyuzhanin D.V.
A rare clinical case of the patient with pulmonary hypertension associated with hereditary hemorrhagic telangiectasia. Case report
Kasparova A.M., Valieva Z.S., Martynyuk T.V.
Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia
Shmalts A.A., Gorbachevsky S.V.
Comparison of the integral indices of the vectorcardiogram with the data of echocardiography in patients with idiopathic and chronic thromboembolic pulmonary hypertension
Sakhnova T.A., Blinova E.V., Belevskaya A.A., Saidova M.A., Arkhipova O.A., Yurasova E.S., Alokova F.H., Martynyuk T.V., Chazova I.Y.
CURRENT RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
Avdeev S.N.
Chronic thromboembolic pulmonary hypertension: current diagnostic and treatment options: A review
Chazova I.E.
Perspectives of using pulmonary arterial stiffness indicators to evaluate the prognosis of patients with pulmonary arterial hypertension
Simakova M.A., Ryzhkov A.V., Kazymly A.V., Naimushin A.V., Lukinov V.L., Moiseeva O.M.
Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis
Volkov A.V., Kurmukov I.A., Iudkina N.N., Glukhova S.I., Nikolaeva E.V.
Pulmonary hypertension in Russia: The first results of the national register
Chazova I.E., Arkhipova O.A., Valieva Z.S., Nakonechnikov S.N., Martyniuk T.V.
The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat
Gratsianskaya S.E., Valieva Z.S., Martynyuk T.V.
A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults
Shmalts A.A., Gorbachevsky S.V.
New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
Martynyuk T.V., Nakonechnikov S.N., Chazova I.Y.
Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension
Tsareva N.A.
Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role
Mukhin N.A., Fomin V.V., Popova E.N., Kuznetsova A.V., Popova I.A., Churganova L.Y., Osipenko V.I., Mukhin N.A., Fomin V.V., Popova E.N., Kuznetsova A.V., Popova I.A., Churganova L.Y., Osipenko V.I.
Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics
Valieva Z.S., Martynyuk T.V.
Patient's way from acute pulmonary embolism to chronic thromboembolic pulmonary hypertension: diagnostic and treatment options
Edemskiy A.G., Ivanov S.N., Kliver E.N., Novikova N.V., Galstyan M.G., Sevastyanov A.V., Cherniavsky A.M.
"Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism
Chazova I.E., Martynyuk T.V., Gorbachevskii S.V., Gramovich V.V., Danilov N.M., Panchenko E.P., Chernyavskiy A.M., Shmalts A.A., Yavelov I.S.
Balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
Danilov N.M., Matchin Y.G., Chernyavsky A.M., Edemsky A.G., Grankin D.S., Sagaydak O.V., Chazova I.E., Boytsov S.A., Karaskov A.M.
Exacerbation of idiopathic pulmonary fibrosis
Avdeev S.N., Gaynitdinova V.V., Merzhoeva Z.M., Neklyudova G.V., Tsareva N.A., Nuralieva G.S.
Possibility of complex medicamental and endovascular treatment of pulmonary hypertension in Takayasu arteritis with predominant pulmonary arteries’ lesion
Маrtynuk T.V., Aleevskaya A.M., Gramovich V.V., Danilov N.M., Korobkova I.Z., Matchin U.G., Solodovnikova L.V., Beketova T.V.
Evolution of pathogenetic therapy of pulmonary arterial hypertension
Chazova I.E., Yarovoy S.Y., Danilov N.M.
SURVIVAL OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION, ASSOCIATED WITH SYSTEMIC SCLEROSIS
Volkov A.V., Martynyuk T.V., Yudkina N.N., Danilov N.M., Glukhova S.I., Guseva N.G., Chazova I.E., Nasonova V.A.
The role of free radical oxidation and endothelial dysfunction in the onset and progression of chronic obstructive pulmonary disease
Kuznetsov A.N., Grigor'eva N.Y., Sharabrin E.G., Kuznetsov A.N., Grigorieva N.Y., Sharabrin E.G.
Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry
Valieva Z.S., Martynyuk T.V., Nakonechnikov S.N., Chazova I.E.
Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases
Grigoryeva N.Y., Maiorova M.V., Korolyova M.E., Samolyuk M.O.
Modern view on the place of riociguat in the treatment of pulmonary hypertension
Valieva Z.S., Taran I.N., Martynyuk T.V., Chazova I.Y.
A patient with severe idiopathic pulmonary arterial hypertension: Is there a way out?
Tsareva N.A., Avdeev S.N., Neklyudova G.V.
Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 1)
Chazova I.E., Martynyuk T.V.
Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension
Martyniuk T.V., Arkhipova O.A., Kobal' E.A., Danilov N.M., Chazova I.E.
Pulmonary hypertension in patients with systemic sclerosis with CREST-syndrome and without it
Karoli N.A., Rebrov A.P., Orlova E.E.
Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future
Martynyuk T.V., Chazova I.E.
COVID-19 and cardiovascular diseases
Chazova I.E., Mironova O.I.
Features of central hemodynamics in patients with community - acquired pneumonia depending on the course of the disease and cardiovascular comorbidity
Titova O.N., Kuzubova N.A., Aleksandrov A.L., Perley V.E., Volchkova E.V., Baryshnikova K.A.
Diagnosis and treatment of pulmonary hypertension: from the point of view of 2017
Sarybaev A.S., Sydykov A.S., Sartmyrzaeva M.A., Mamazhakypov A.T., Maripov A.M., Dzhumagulova A.S.
Bosentan use in pulmonary arterial hypertension: Russian and foreign experience
Valieva Z.S., Martynyuk T.V., Chazova I.E.
Right ventricular diastolic function in patients with lung diseases in the absence or presence of pulmonary hypertension
Sumin A.N., Arkhipov O.G.
Role of vascular remodeling markers in the development of osteoporosis in idiopathic pulmonary arterial hypertension
Nevzorova V.A., Kochetkova E.A., Ugay L.G., Maistrovskaya Y.V., Khludeeva E.A.
Choice of novel endpoints in clinical trials evaluating the efficiency of drug therapy in patients with pulmonary hypertension
Avdeev S.N.
Chronic obstructive pulmonary disease and associated illnesses
Chuchalin A.G.
Vasaprostan treatment of fibrosing alveolitis in patients withpulmonary hypertension
Popova E.N., Bolevich S.В., Litvitsky P.E., Arkhipova D.V., Osipenko V.I., Kogan E.A., Kornev В.М., Mukhin N.A.
Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome
Movsisyan G.A., Martynyuk T.V., Mershin K.V., Danilov N.M., Satybaldyeva M.A., Reshetnyak T.M., Akchurin R.S., Nasonov E.L., Chazova I.Y.
Analysis of the management of hypertension complications in patients during emergency care
Alpysova A.R., Subbota Y.V., Adambekova A.K., Telembetov N.T., Maratkyzy M.
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
Rudenko T.E., Vasilyeva M.P., Solomakhina N.I., Kutyrina I.M.
Chronic obstructive pulmonary disease concurrent with hypertension: Evaluation of the therapeutic effect of prolonged-release indapamide
Ovcharenko S.I., Morozova T.E., Nersesyan Z.N.
Bosentan: A considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases
Volkov A.V., Iudkina N.N., Nikolaeva E.V., Kurmukov I.A., Glukhova S.I., Nasonov E.L.
Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension
Martyniuk T.V., Zykov K.A., Antonova O.I., Rvacheva A.V., Arkhipova O.A., Kobal' E.A., Masenko V.P., Chazova I.E.
Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension
Arkhipova D.V., Privalova E.V., Kozlovskaya L.V., Kornev B.M., Popova E.N., Kraeva V.V., Osipenko V.I., Bitsadze V.O.
Efficacy and safetyof different p-blockers in patients with isolated systolic hypertension, associated with diabetes mellitus and obstructive pulmonary diseases
Kukes V.G., Ostroumova O.D., Mamaev V.I., Batutina A.M., Abakumov Y.E., Zykova A.A.
Pulse wave velocity and other indicators of arterial stiffness in hypertension comorbidity and chronic obstructive pulmonary disease
Aksenova T.A., Gorbunov V.V., Tsarenok S.Y.
Subtraction CT angiopulmonographic assessment of the vascular bed and lung perfusion in patients with chronic thromboembolic pulmonary hypertension: A pilot study
Veselova T.N., Demchenkova A.Y., Martynyuk T.V., Danilov N.M., Ternovoy S.K., Chazova I.E.
Chronic obstructive pulmonary disease and comorbidities
Chuchalin A.G.
Tissue myocardial Doppler echocardiographic evaluation of right heart function and the level natriuretic peptides in patients with pulmonary hypertension of various etiologies
Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E., Andreeva Y.A., Saidova M.A., Martynyuk T.V., Masenko V.P., Chazova I.E.
Risk stratification methods and their significance in pulmonary arterial hypertension
Avdeev S.N., Tsareva N.A.
The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation
Chazova I.E., Martynyuk T.V., Valieva Z.S., Nakonechnikov S.N., Nedogoda S.V., Salasyuk A.S., Taran I.N., Gratsianskaya S.E.
Clinical and hemodynamic characteristics and possibilities for therapy in patients with severe (functional class IV) pulmonary arterial hypertension associated with diffuse connective tissue diseases
Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Novikova D.S., Markelova E.I., Volkov A.V.
Natriuretic peptides in diagnosis of pulmonary hypertension
Kuznetsova A.V., Fomin V.V., Popova I.A., Popova E.N., Kuznetsova A.V., Fomin V.V., Popova I.A., Popova E.N.
Blockers of angiotensin receptors: a novel approach to treatment of secondary pulmonary hypertension
Butorov I.V., Verbitsky О.N., Butorov S.I.
Role of some neurohumoral factors in the development of pulmonary hypertension in patients with interstitial Jung diseases
Arkhipova D.V., Kornev B.M., Popova E.N., Kogan E.A., Osipenko V.I., Privalova E.V., Kobylensky A.G., Mescheryakova S.A., Efremov E.E.
Survival in pulmonary arterial hypertension, associated with connective tissue diseases, treated by sildenafil: results of the prospective study
Volkov A.V., Nikolaeva E.V., Yudkina N.N., Kurmukov I.A., Nasonov E.L.
HIV/AIDS masks in a therapist’s practice
Roshchina A.A., Ponomareva E.Y., Rebrov A.P.
First clinical experience with endothelin receptor antagonist bosentan used in patients with pulmonary hypertension: results of a one-year study
Avdeev S.N., Tsareva N.A., Nekliudova G.V., Chuchalin A.G.
Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study
Martyniuk T.V., Konosova I.D., Chazova I.E.
Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension
Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoylenko L.E., Chazova I.E., Arkhipova O.A., Martynyuk T.V., Lazutkina V.K., Ataullakhanova D.M., Stukalova O.V., Danilov N.M., Samoilenko L.E., Chazova I.E.
Prostaglandin E1. Mechanisms of action and clinical potentialities
Alferov A.V., Aizenberg L.V.
Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat
Martynyuk T.V., Shmalts A.A., Gorbachevsky S.V., Chazova I.E.
Clinical guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (Part 2)
Chazova I.E., Martynyuk T.V.
Progressive pulmonary hypertension in a patient with type 1 Gaucher disease
Ponomarev R.V., Model S.V., Averbukh O.M., Gavrilov A.M., Galstyan G.M., Lukina E.A.
Non-drug rehabilitation of patients with chronic obstructive pulmonary disease concurrent with hypertension
Sevostyanova E.V., Nikolaev Y.A., Bogdankevich N.V., Lusheva V.G., Markova E.N., Dolgova N.A.
Pulmonary hypertension in rheumatic heart disease: current approaches to diagnosis and therapy
Shostak N.A., Klimenko A.A., Novikov I.V., Demidova N.A., Aksenova A.V.
Vasoregulating activity of the endothelium and pulmonary hypertension
Karoli N.A., Rebrov A.P.
Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension
Moisseeva O.M., Rudakova A.V.
A clinical case of long-term macitentan therapy in a female patient with idiopathic pulmonary hypertension
Arkhipova O.A., Martynyuk T.V., Chazova I.E.
The new endothelin receptor antagonist macitentan: Prospects for therapy of pulmonary arterial hypertension
Avdeev S.N.
Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan
Avdeev S.N.
Clinical guidelines for the diagnosis and treatment of pulmonary hypertension
Chazova I.E., Avdeev S.N., Tsareva N.A., Volkov A.V., Martyniuk T.V., Nakonechnikov S.N.
1 - 85 of 85 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies